gms | German Medical Science

27. Deutscher Krebskongress

Deutsche Krebsgesellschaft e. V.

22. - 26.03.2006, Berlin

Ultraradical resection of thyroid carcinoma: surgical heroism or multilation?

Meeting Abstract

Suche in Medline nach

  • corresponding author presenting/speaker Markus Dürsch - Universitätsklinikum, Erlangen, Deutschland
  • B. Reingruber - Universitätsklinikum, Erlangen
  • W. Hohenberger - Universitätsklinikum, Erlangen

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPO253

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dkk2006/06dkk363.shtml

Veröffentlicht: 20. März 2006

© 2006 Dürsch et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

In medullary thyroid carcinoma, surgery is the only validated therapeutic option. We report the case of a 12 year old girl with a metastatic and locally advanced medullary thyroid carcinoma. At the time of presentation, the patient had severe obstructive respiratory failure due to a thyroid tumor which had grossly infiltrated a long tracheal segment, both recurrent nerves and the esophagus. Furthermore, large bilateral cervical lymph node metastases reached up to the base of the skull. In July 2004 we performed a multivisceral resection of the thyroid including a 4cm segment of the trachea, the recurrent nerves, the anterior esophageal wall and an extended radical bilateral neck dissection. Additionally, a tracheostomy and a gastrostomy had to be created. Macroscopically, the tumor could cmpletely resected. Histopathological staging revealed a medullary thyroid carcinoma UICC IV (pT4, pN1 (56/82), L1, V0, M0, R1). The girl was included in an experimental study protool of a combined high dose radio-chemotherapy. She has been followed up in 3 monthly intervals and has no evidence of residual disease or recurrence today, 18 months after surgery. With view to her permanent functional impairments we will discuss whether this ultra-radical surgical approach is justifiable.